Potassium channel KCNA1 modulates oncogene-induced senescence and transformation

Cancer Research

Volumn 73, Issue 16, 2013, Pages 5253-5265

  Lallet Daher, Hélène ^a,b,c   Wiel, Clotilde ^a,b,c   Gitenay, Delphine ^a,b,c   Navaratnam, Naveenan ^d   Augert, Arnaud ^a,b,c   Calvé, Benjamin Le ^a,b,c   Verbeke, Stéphanie ^e   Carling, David ^d   Aubert, Sébastien ^f,g   Vindrieux, David ^a,b,c   Bernard, David ^a,b,c  

^a CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^b CENTRE LÉON BÉRARD   (France)

^c UNIVERSITÉ DE LYON   (France)

^d MRC CLINICAL SCIENCES CENTRE   (United Kingdom)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f Faculté DeMedecine   (France)

^g JEAN PIERRE AUBERT RESEARCH CENTER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; POTASSIUM CHANNEL KV1.1; RAS PROTEIN;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; ENZYME ACTIVITY; GENETIC SCREENING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MALIGNANT TRANSFORMATION; MEMBRANE POTENTIAL; ONCOGENE; ONCOGENE INDUCED SENESCENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SENESCENCE; STRESS; TUMOR GROWTH;

EID: 84882732015     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-3690     Document Type: Article

References (41)

1. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998;279:349-52.
2. Vaziri H, Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 1998;8:279-82.
3. Adams PD. Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence. Mol Cell 2009;36:2-14.
4. Collado M, Serrano M. Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 2010;10:51-7.
5. Serrano M, Lin AW,McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997;88:593-602.
6. Ben Porath I, Weinberg RA. The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 2005;37:961-76.
7. Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S, et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 2008;133:1006-18.
8. d'Adda di Fagagna F. Living on a break: cellular senescence as a DNAdamage response. Nat Rev Cancer 2008;8:512-22,.
9. Kuilman T, Michaloglou C, Vredeveld LCW, Douma S, van Doorn R, Desmet C J, et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008;133: 1019-31.
10. Young AR, Narita M, Ferreira M, Kirschner K, Sadaie M, Darot JF, et al. Autophagy mediates the mitotic senescence transition. Genes Dev 2009;23:798-803.
11. Itahana K, Campisi J, Dimri G. Mechanisms of cellular senescence in human and mouse cells. Biogerontology 2004;5:1-10.
12. Christoffersen NR, Shalgi R, Frankel LB, Leucci E, Lees M, Klausen M, et al. p53-independent upregulation of miR-34a during oncogeneinduced senescence represses MYC. Cell Death Differ 2010;17: 236-45.
13. Ewald JA, Desotelle JA, Wilding G, Jarrard DF. Therapy-induced senescence in cancer. J Natl Cancer Inst 2010;102:1536-46.
14. Humbert N, Navaratnam N, Augert A, Da Costa M, Martien S, Wang J, et al. Regulation of ploidy and senescence by the AMPK-related kinase NUAK1. EMBO J 2010;29:376-86.
15. Lin HK, Chen Z, Wang G, Nardella C, Lee SW, Chan CH, et al. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence. Nature 2010;464:374-9.
16. Scurr LL, Pupo GM, Becker TM, Lai K, Schrama D, Haferkamp S, et al. IGFBP7 is not required for B-RAF-induced melanocyte senescence. Cell 2010;141:717-27.
17. Cipriano R, Kan CE, Graham J, Danielpour D, Stampfer M, Jackson MW. TGF-beta signaling engages an ATM-CHK2-p53-independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells. Proc Natl Acad Sci USA 2011;108: 8668-73.
18. Bianchi-Smiraglia A, Nikiforov MA. Controversial aspects of oncogene- induced senescence. Cell Cycle 2012;11:4147-51.
19. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998;396:84-8.
20. Morita S, Kojima T, Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 2000;7:1063-6.
21. Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M. Rafinduced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol 1997;17: 5598-611.
22. Boehm JS, Zhao JJ, Yao J, Kim SY, Firestein R, Dunn IF, et al. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 2007;129:1065-79.
23. Vuong BQ, Lee M, Kabir S, Irimia C, Macchiarulo S, McKnight GS, et al. Specific recruitment of protein kinase A to the immunoglobulin locus regulates class-switch recombination. Nat Immunol 2009;10:420-6.
24. Bernard D, Quatannens B, Begue A, Vandenbunder B, Abbadie C. Antiproliferative and antiapoptotic effects of crel may occur within the same cells via the up-regulation of manganese superoxide dismutase. Cancer Res 2001;61:2656-64.
25. Augert A, Payre C, de Launoit Y, Gil J, Lambeau G, Bernard D. The Mtype receptor PLA2R regulates senescence through the p53 pathway. EMBO Rep 2009;10:271-7.
26. Brevet M, Ahidouch A, Sevestre H, Merviel P, El Hiani Y, Robbe M, et al. Expression of K+ channels in normal and cancerous human breast. Histol Histopathol 2008;23:965-72.
27. Acosta JC, O'Loghlen A, Banito A, Raguz S, Gil J. Control of senescence by CXCR2 and its ligands. Cell Cycle 2008;7:2956-9.
28. Courtois-Cox S, Genther Williams SM, Reczek EE, Johnson BW, McGillicuddy LT, Johannessen CM, et al. A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell 2006;10:459-72.
29. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, et al. Tumour biology: Senescence in premalignant tumours. Nature 2005;436:642.
30. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, et al. Crucial role of p53-dependent cellular senescence in suppression of Ptendeficient tumorigenesis. Nature 2005;436:725-30.
31. Levin G, Chikvashvili D, Singer-Lahat D, Peretz T, Thornhill WB, Lotan I. Phosphorylation of a K ?channel alpha subunit modulates the inactivation conferred by a beta subunit. Involvement of cytoskeleton. J Biol Chem 1996;271:29321-8.
32. Chandy KG, Williams CB, Spencer RH, Aguilar BA, Ghanshani S, Tempel BL, et al. A family of three mouse potassium channel genes with intronless coding regions. Science 1990;247:973-5.
33. McCoy MS, Toole JJ, Cunningham JM, Chang EH, Lowy DR, Weinberg RA. Characterization of a human colon/lung carcinoma oncogene. Nature 1983;302:79-81.
34. Vire E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 2005;439:871-4.
35. Kirmizis A, Bartley SM, Kuzmichev A, Margueron R, Reinberg D, Green R, et al. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys Genes Dev 2004;18:1592-605.
36. Ballestar E, Esteller M. Epigenetic gene regulation in cancer. Adv Genet 2008;61:247-67.
37. TsaiHC, Baylin SB. Cancer epigenetics: linking basic biology to clinical medicine. Cell Res 2011;21:502-17.
38. Allen ML, Koh DS, Tempel BL. Cyclic AMP regulates potassium channel expression in C6 glioma by destabilizing Kv1.1 mRNA. Proc Natl Acad Sci U S A 1998;95:7693-8.
39. Naviglio S, Caraglia M, Abbruzzese A, Chiosi E, Di Gesto D, Marra M, et al. Protein kinase A as a biological target in cancer therapy. Expert Opin Ther Targets 2009;13:83-92.
40. Francis H, Glaser S, Ueno Y, Lesage G, Marucci L, Benedetti A, et al. cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ ERK1/2 pathway. J Hepatol 2004;41:528-37.
41. Gomes E, Papa L, Hao T, Rockwell P. The VEGFR2 and PKA pathways converge at MEK/ERK1/2 to promote survival in serum deprived neuronal cells. Mol Cell Biochem 2007;305:179-90.